Article Details

With $191M Haul, Maze Therapeutics Takes Aim at Genetic Diseases

Retrieved on: 2019-02-27 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

With $191M Haul, Maze Therapeutics Takes Aim at Genetic Diseases. View article details on hiswai:

Excerpt

<div>Maze Therapeutics is launching today with $191 million from investors led by <b>Third Rock Ventures</b> and Arch Venture Partners, both known for pouring ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up